VAXZEVRIA

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain.

Active ingredients

The drug VAXZEVRIA contains one active pharmaceutical ingredient (API):

1	COVID-19 Vaccine AstraZeneca UNII B6L4N5Z4GH - SARS-COV-2
	SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is a monovalent vaccine composed of a single recombinant, replication-deficient chimpanzee adenovirus (ChAdOx1) vector encoding the S glycoprotein of SARS-CoV-2. The SARS-CoV-2 S immunogen in the vaccine is expressed in the trimeric pre-fusion conformation; the coding sequence has not been modified in order to stabilise the expressed S-protein in the pre-fusion conformation. Following administration, the S glycoprotein of SARS-CoV-2 is expressed locally stimulating neutralising antibody and cellular immune responses, which may contribute to protection to COVID-19.
	Read more about SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VAXZEVRIA Suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BN02		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1836840, 1836851
ES	Centro de información online de medicamentos de la AEMPS	1211529001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	553555
FR	Base de données publique des médicaments	61875116
JP	医薬品医療機器総合機構	631341FA1024
LT	Valstybinė vaistų kontrolės tarnyba	1091787, 1091788
NL	Z-Index G-Standaard, PRK	61107
NZ	Medicines and Medical Devices Safety Authority	22180
PL	Rejestru Produktów Leczniczych	100447040
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67527001, W67527002